VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 52 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,791 | +4439.6% | 11,715 | +7869.4% | 0.01% | – |
| Q4 2019 | $2,000 | 0.0% | 147 | +36.1% | 0.00% | – |
| Q3 2019 | $2,000 | -33.3% | 108 | -9.2% | 0.00% | – |
| Q2 2019 | $3,000 | +200.0% | 119 | +58.7% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 75 | -52.2% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 157 | +282.9% | 0.00% | – |
| Q3 2018 | $1,000 | -88.9% | 41 | -91.8% | 0.00% | -100.0% |
| Q1 2018 | $9,000 | -62.5% | 500 | -76.7% | 0.00% | -66.7% |
| Q2 2016 | $24,000 | – | 2,143 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |